Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
NSAIDs Contribute to Increased CVD Risk in Osteoarthritis
FDA: Data Integrity Issue With Recently Approved Gene Therapy
FDA Approves First Treatment for Tenosynovial Giant Cell Tumor
Boxed Warning Added to Tofacitinib Prescribing Information
Anti-TNF Biosimilar Hadlima Receives FDA Approval
Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis
Opioids Commonly Prescribed to Gout Patients Discharged From the ED
Romosozumab Shows Positive Bone Formation Results in Study
Triclosan Exposure May Lower Bone Mineral Density in Women
Exposure to Anticholinergics May Increase Dementia Risk
Elderly Women May Still Benefit From Osteoporosis Treatment
Botox Approved to Treat Pediatric Patients With Upper Limb Spasticity
Results From Phase 3 Guselkumab PsA Trials Announced
Live-Attenuated Vaccines Appear Safe for Children With Rheumatic Diseases
Subcutaneous Formulation of Infliximab Biosimilar CT-P13 Investigated in RA Patients
Tofacitinib Ext-Rel Monotherapy Effective for Moderate to Severe RA After Methotrexate Withdrawal
Emflaza Approved for Younger Patients With Duchenne Muscular Dystrophy
First Gene Therapy for Pediatric Patients With Spinal Muscular Atrophy Gets FDA Approval
